Owler | Instant Insight

Partnership

Monte Rosa Therapeutics Announces Collaboration with Novartis for Degraders to Treat Immune-mediated Diseases

Novartis receives an exclusive license to an undisclosed discovery target Novartis also receives options to license two programs from Monte Rosa's growing

centralcharts

About | Owler for Enterprise | Support | Unsubscribe

Use of Owler products is governed by our Terms of Use and Privacy Policy